Compare REPL & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | CPF |
|---|---|---|
| Founded | 2015 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 802.1M |
| IPO Year | 2018 | 2011 |
| Metric | REPL | CPF |
|---|---|---|
| Price | $7.65 | $31.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $11.13 | ★ $35.50 |
| AVG Volume (30 Days) | ★ 1.4M | 140.4K |
| Earning Date | 05-21-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.68% |
| EPS Growth | 5.25 | ★ 45.18 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $51,817,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.37 |
| P/E Ratio | ★ N/A | $11.01 |
| Revenue Growth | N/A | ★ 33.81 |
| 52 Week Low | $2.68 | $23.16 |
| 52 Week High | $13.24 | $35.01 |
| Indicator | REPL | CPF |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 52.79 |
| Support Level | $6.71 | $30.17 |
| Resistance Level | $8.07 | $33.35 |
| Average True Range (ATR) | 0.49 | 0.73 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 80.07 | 84.11 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.